For the fifth consecutive year, the Bass, Berry & Sims
Healthcare Private Equity Team hosted BBS Connect, a forum to connect healthcare dealmakers during the annual J.P. Morgan Healthcare Conference.
Over three days –
January 11-13, 2021 – we brought together senior executives and healthcare dealmakers on the front lines of the healthcare industry’s hottest sectors. Our sector-focused sessions included insights into deals completed in 2020, opportunities and challenges healthcare companies will face in 2021, the current M&A environment and investment trends, and lingering impacts from the past year. Despite these unprecedented and unpredictable times, healthcare M&A activity did not decline as sharply as many predicted, even rebounding in the second half of the year. Across all of our sector-focused discussions, panelists shared an optimistic outlook with strategic opportunities continuing in 2021.
Artificial Intelligence (AI) has had a profound impact on numerous sectors. In healthcare, too, AI seems to have made a considerable mark. But exactly how much of that is hype and what is real?
Here s Why You Should Hold on to Cerner (CERN) Stock Now Zacks.com 12/31/2020
Cerner Corporation CERN is well poised for growth on the back of big data-based electronic health records (EHR) system and strategic deals. However, stiff competition remains a concern.
Popular Searches
Shares of Cerner have gained 6.2% in a year’s time compared with the industry’s growth of 30.4%. Meanwhile, the S&P 500 Index has rallied 17.7% in the same time frame.
The company, with a market capitalization of $23.91 billion, offers healthcare information technology (HCIT) solutions worldwide. It anticipates earnings to improve 11.9% over the next five years. Moreover, the company has a trailing four-quarter earnings surprise of 3%, on average.